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August 24, 2010:742–6f such clinical trials may help to explain the relatively low awareness
f OSA as an important consideration in the patient with MI.
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Letters to the Editor
iscordance of
ndividual Risk Estimates
he excellent review by Berger et al. (1) perfectly illustrates a
roblem with individual risk prediction, which is that different
isk scores provide different risk estimates for the same patient. Hable 2 of their paper (1) shows estimated risks ranging from
% to 39% for a patient asking about her risk of a future
ardiovascular event. Much of this discordance represents the
ifferent outcomes and different time periods used in the various
ardiovascular risk scores. But even 10-year global cardiovascu-
ar risk ranges from 6% to 14%. This is a large discordance, and
ifferent preventive measures may be offered depending on the
hoice of a cardiovascular risk score.
When the U.S. Preventive Services Task Force published
uidelines on aspirin for prevention of cardiovascular disease,
orrespondents raised the same point, suggesting the guidelines be
eissued “with a specific risk-assessment tool that has been thor-
ughly studied to ensure the clinically appropriate application of
hese important guidelines” (2). The authors responded that
evelopment of a “gold-standard” cardiovascular disease risk cal-
ulator was a pressing priority (3). However, a recent review found
any examples of the discordance of individual risk estimates and
oncluded that such discordance was unavoidable (4). The reason
or this is that individuals do not have definite, pre-existing
robabilities of a cardiovascular outcome that can be precisely
stimated. In mathematical terms, the problem of risk stratification
oes not have a unique solution.
How do the authors manage such discordant individual risk
stimates in the clinic?
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e thank Dr. Stern for his interest in our paper (1), and agree
bout the difficult clinical challenge facing physicians in cardiovas-
ular prevention. How does one deal with seemingly discordant
isk scores in the clinical decision making process? Because the
oal of providers is to prevent or postpone the occurrence of
isease, understanding a patient’s risk of disease is essential.
evertheless, risk estimation is a probabilistic exercise rather than
definitive answer and therefore will always have some uncer-
ainty, even if we rely on a single “gold-standard” risk equation.
owever, there are a variety of risk scores that incorporate different
